Active ingredients of CHM |
Triterpenoids |
Astragaloside IV |
Noise-induced hearing loss in guinea pigs |
Reducing iNOS, nitrotyrosine, and active caspase 3 |
48, 49, 50, 51, 52, 53, 54
|
Ursolic acid |
Cisplatin-induced ototoxicity in BALB/c mice |
Inhibiting TRPV1-oxidative stress pathway |
55, 56, 57
|
Ginsenoside Rb1 |
Gentamicin-induced hearing loss in SD rats; cochlear ischemia-induced hearing loss in Mongolian gerbils |
Reducing ROS and inhibiting apoptosis |
58, 59, 60
|
Ginsenoside Rd |
Noise-induced hearing loss in guinea pigs |
Alleviating apoptosis, oxidative stress, and activating SIRT1/PGC-1α signaling pathway |
61 |
Polyphenols |
Rosmarinic acid |
Cisplatin-induced ototoxicity in rat explants; noise-induced hearing loss in Wistar rats |
Inhibiting apoptosis and reducing ROS; potentiating Nrf2–ARE signaling pathway |
62, 63, 64
|
Curcumin |
Gentamicin and sodium salicylates-induced ototoxicity in SD rats |
Inhibiting oxidative stress, apoptosis, and inflammation |
65, 66, 67, 68, 69, 70
|
Resveratrol |
Cisplatin-induced ototoxicity in mice; kanamycin and furosemide-induced ototoxicity in Wistar rats; noise-induced hearing loss in C57BL/6 mice; age-related hearing loss in C57BL/6 mice |
Activating PTEN-PI3K-Akt axis; inhibiting oxidative stress, apoptosis and inflammation |
71, 72, 73, 74, 75
|
Epicatechin |
Radiation-induced ototoxicity in zebrafish and SD rats; cisplatin-induced ototoxicity in SD rats |
Inhibiting oxidative stress and apoptosis |
76,77
|
|
EGCG |
Cisplatin-induced ototoxicity in Wistar rats; amikacin and gentamicin-induced hearing loss in zebrafish |
Reducing ROS and inhibiting ERK1/2 and STAT1; inhibiting apoptosis |
78,79
|
Flavonoids |
Galangin |
Amikacin-induced ototoxicity in ICR mouse cochlear explants |
Inhibiting oxidative stress |
80, 81, 82
|
Luteolin |
Hydrogen peroxide-induced cellular senescence model in HEI-OC1 |
Promoting sirtuin 1 expression and inhibiting oxidative stress |
83 |
Hesperetin |
Cisplatin-induced ototoxicity in Wistar rats |
Increasing antioxidant enzymes and reducing oxidant parameters |
84 |
Puerarin |
Noise-induced hearing loss in C57 mice; gentamicin-induced ototoxicity in C57BL/6J mice |
Regulating the expression of PKCγ and GABABR; reducing ROS and inhibiting mitochondria-dependent apoptosis |
85, 86, 87
|
Terpenoids |
Ginkgolide B |
Cisplatin-induced ototoxicity in SD rats |
Reducing ROS and inhibiting mitochondrial apoptosis |
88 |
Oleuropein |
Noise-induced hearing loss in Wistar rats |
Reducing ABR hearing threshold shifts and attenuating SGN damage |
89 |
Oridonin |
Noise-induced hearing loss in C57 mice; kanamycin-induced hearing loss in Kunming mice |
Inhibiting NLRP3-inflammasome activation and caspase-1/GSDMD-related hair cell pyroptosis |
90,91
|
Saccharides |
LBP |
Cisplatin-induced ototoxicity in SD rats |
Reducing ROS and maintaining mitochondrial potential |
92,93
|
Extracts of single CHM |
Salvia miltiorrhiza |
Gentamicin and cisplatin-induced ototoxicity in guinea pigs |
Decreasing iNOS and caspase-3 expression |
94, 95, 96
|
Ginkgo biloba |
Gentamicin-induced ototoxicity in guinea pigs; cisplatin-induced ototoxicity in Wistar rats; noise-induced hearing loss in SD rats |
Reducing ROS and NO and inhibiting apoptosis |
97, 98, 99, 100, 101, 102
|
Astragalus membranaceus |
Noise-induced hearing loss in guinea pigs |
Reducing the change of connexin 26 in stria vascularis |
103,104
|
Rehmannia glutinosa |
Cisplatin-induced ototoxicity in HEI-OC1 cells |
Increasing activity of antioxidant enzymes; inhibiting lipid peroxidation and scavenging activities of free radicals |
106, 107, 108
|
Curculigo orchioides |
Cisplatin and noise-induced hearing loss in ICR mice |
Inhibiting lipid peroxidation and scavenging activities against free radicals |
109, 110, 111
|
CHM prescriptions |
Erlong Zuoci |
Age-related hearing loss in C57 mice; gentamicin-induced ototoxicity in Kunming mice |
Inhibiting mitochondrial apoptosis |
112, 113, 114
|
Jian Er |
Age-related hearing loss in C57 mice |
Inhibiting oxidative stress and mitochondrial apoptosis |
119 |